Daily Archives: September 19, 2021
CDC Report: Moderna’s vaccine associated with greater effectiveness (93%) against Covid-19 hospitalization compared to Pfizer (88%) and J&J (71%) vaccines.
19 Sep, 2021 | 23:48h | UTCCommentaries:
CDC: Moderna COVID vaccine most protective against hospital cases – CIDRAP
CDC data: Moderna vaccine has edge in preventing COVID-19 hospitalizations – UPI
Commentary on Twitter
Turns out all vaccines are not equal! https://t.co/yP6eC6o78i via @CDCgov Among adults without immunocompromising conditions, vaccine effectiveness against COVID-19 hospitalization (Mar 11–Aug 15, 21) was ⬆️for @moderna_tx (93%) than @pfizer (88%) and @JNJNews vaccine (71%).
— Carlos del Rio (@CarlosdelRio7) September 17, 2021
Does everybody need a booster shot? – “Why some people might need Covid-19 booster shots — and some might not”.
19 Sep, 2021 | 23:43h | UTCDoes everybody need a booster shot? – Vox
An FDA panel says only high-risk Americans and those 65+ should get covid boosters.
19 Sep, 2021 | 23:45h | UTCAn FDA Panel Says Only High-Risk Americans And Those 65+ Should Get COVID Boosters – NPR
See also:
5 reasons why FDA advisers did not recommend Covid-19 booster shots for everyone – CNN
Top doctors say not so fast to Biden’s boosters-for-all plan – Associated Press
Related:
Third shot: UK to offer COVID booster jabs to over 50s.
COVID-19 vaccine efficacy does not support boosters for general population, review concludes.
COVID vaccine effects wane over time but still prevent death and severe illness.
What’s the evidence for COVID-19 booster shots?
COVID vaccine immunity is waning — how much does that matter? – “As debates about booster shots heat up, what’s known about the duration of vaccine-based immunity is still evolving”.
19 Sep, 2021 | 23:40h | UTCCOVID vaccine immunity is waning — how much does that matter? – Nature
Opinion | Vaccinate the World before Starting COVID Booster Shots – “Fewer than 0.5 percent of vaccine doses have been distributed to people living in low-income countries”.
19 Sep, 2021 | 23:41h | UTCVaccinate the World before Starting COVID Booster Shots – Scientific American
Review: Long COVID symptoms in children rarely persist beyond three months.
19 Sep, 2021 | 23:47h | UTCNews release: Long COVID symptoms in children rarely persist beyond three months – Murdoch Children’s Research Institute
Original study: How Common Is Long COVID in Children and Adolescents? – The Pediatric Infectious Disease Journal
Commentary: Long Covid in children and adolescents is less common than previously feared – The Guardian
Related:
Cohort study: Risk factors for long covid in previously hospitalized children.
M-A: More than 50 long-term effects of COVID-19.
Commentary on Twitter (thread – click for more)
We reviewed 14 studies of persisting symptoms following #COVID19 in #children & #adolescents
Most had major limitations and should be interpreted with caution.
True risk is likely to be nearer 1 in 100 than often quoted 1 in 7.#medpeds #IDTwitter
(Long) ?1/n pic.twitter.com/YL2h516sNX
— Nigel Curtis (@nigeltwitt) September 17, 2021
Side effect patterns in a crossover trial of statin, placebo, and no treatment – This N-of-1 trial, now published in full, suggests the nocebo effect causes most of statins muscle adverse effects.
19 Sep, 2021 | 23:30h | UTC
WHO/ILO: Almost 2 million people die from work-related causes each year.
19 Sep, 2021 | 23:39h | UTCNews release: WHO/ILO: Almost 2 million people die from work-related causes each year – World Health Organization
Commentary on Twitter
.@WHO & @ilo launched today the first set of joint estimates on the work-related burden of disease and injury: more than 1.9 million people die every year due to exposure from risk factors at the workplace. Nobody should die for their job. https://t.co/44j57rdCLK #WorkersHealth pic.twitter.com/vlncAHMoGK
— Tedros Adhanom Ghebreyesus (@DrTedros) September 17, 2021
Non-alcoholic fatty liver disease: A patient guideline.
19 Sep, 2021 | 23:35h | UTCNon-alcoholic fatty liver disease: A patient guideline – JHEP Reports
Commentary on Twitter
Finally, here is a guideline specifically designed for patients with NAFLD ?#4KMedEd #LiverTwitter
(Courtesy of @JHEP_Reports)https://t.co/wGTr50fMyE pic.twitter.com/5djcqKigeB
— Keith Siau (@drkeithsiau) September 19, 2021
Large cohort study suggests routine replacement (every 96 hours) of peripheral intravenous catheters may reduce the risk of bloodstream infections compared to clinically indicated replacement.
19 Sep, 2021 | 23:34h | UTCComparison of Routine Replacement With Clinically Indicated Replacement of Peripheral Intravenous Catheters – JAMA Internal Medicine (free for a limited period)
Related Cochrane Review with different findings: Systematic Review: Clinically‐indicated vs. Routine Replacement of Peripheral Venous Catheters
Commentary on Twitter
Phlebitis due to peripheral venous catheters is not a proxy for bloodstream infection. A large prospective study shows that clinically indicated replacement of peripheral venous catheters may put patients at risk of bloodstream infection https://t.co/SNo4SpfoKE
— JAMA Internal Medicine (@JAMAInternalMed) September 17, 2021
Lamotrigine in the maintenance treatment of bipolar disorder.
19 Sep, 2021 | 23:25h | UTCLamotrigine in the maintenance treatment of bipolar disorder – Cochrane Library
Summary: Lamotrigine as a treatment for prevention of recurrence of bipolar disorder – Cochrane Library
Editorial: Brain health and its social determinants.
19 Sep, 2021 | 23:28h | UTCBrain health and its social determinants – The Lancet
Commentary on Twitter
Strong statement from @TheLancet on social determinants of mental health. The American Psychiatric Association has embraced it, as has @rcpsych https://t.co/JfRcj7KXvq
— Sir Michael Marmot (@MichaelMarmot) September 17, 2021
Choosing Wisely: Five things clinicians and patients should question in rural medicine.
19 Sep, 2021 | 23:26h | UTCChoosing Wisely Canada: Rural medicine list of recommendations – Canadian Journal of Rural Medicine
See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada
Roux‐en‐Y versus Billroth‐I reconstruction after distal gastrectomy for gastric cancer.
19 Sep, 2021 | 23:24h | UTC